These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21536082)

  • 1. Efficient disulfide bond formation in virus-like particles.
    Bundy BC; Swartz JR
    J Biotechnol; 2011 Jul; 154(4):230-9. PubMed ID: 21536082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis.
    Smith MT; Varner CT; Bush DB; Bundy BC
    Biotechnol Prog; 2012; 28(2):549-55. PubMed ID: 22125293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein.
    Ishizu KI; Watanabe H; Han SI; Kanesashi SN; Hoque M; Yajima H; Kataoka K; Handa H
    J Virol; 2001 Jan; 75(1):61-72. PubMed ID: 11119574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative description of in vitro assembly of human papillomavirus 16 virus-like particles.
    Mukherjee S; Thorsteinsson MV; Johnston LB; DePhillips PA; Zlotnick A
    J Mol Biol; 2008 Aug; 381(1):229-37. PubMed ID: 18585738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles.
    Lipin DI; Chuan YP; Lua LH; Middelberg AP
    Arch Virol; 2008; 153(11):2027-39. PubMed ID: 18979257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli-based cell-free synthesis of virus-like particles.
    Bundy BC; Franciszkowicz MJ; Swartz JR
    Biotechnol Bioeng; 2008 May; 100(1):28-37. PubMed ID: 18023052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of virus-like particles for gene transfer.
    Petry H; Goldmann C; Ast O; Lüke W
    Curr Opin Mol Ther; 2003 Oct; 5(5):524-8. PubMed ID: 14601522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein.
    Sugahara F; Uchiyama T; Watanabe H; Shimazu Y; Kuwayama M; Fujii Y; Kiyotani K; Adachi A; Kohno N; Yoshida T; Sakaguchi T
    Virology; 2004 Jul; 325(1):1-10. PubMed ID: 15231380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parvovirus B19 virus-like particles: In vitro assembly and stability.
    Sánchez-Rodríguez SP; Münch-Anguiano L; Echeverría O; Vázquez-Nin G; Mora-Pale M; Dordick JS; Bustos-Jaimes I
    Biochimie; 2012 Mar; 94(3):870-8. PubMed ID: 22192916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation.
    Chen PL; Wang M; Ou WC; Lii CK; Chen LS; Chang D
    FEBS Lett; 2001 Jul; 500(3):109-13. PubMed ID: 11445066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment.
    Zhao Q; Wang Y; Abraham D; Towne V; Kennedy R; Sitrin RD
    Biochem Biophys Res Commun; 2011 May; 408(3):447-53. PubMed ID: 21527246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
    Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
    Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-based virus-like particles as a new protein delivery tool.
    Muratori C; Bona R; Federico M
    Methods Mol Biol; 2010; 614():111-24. PubMed ID: 20225039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the DxxDxD motif in the assembly and stability of betanodavirus particles.
    Wu YM; Hsu CH; Wang CH; Liu W; Chang WH; Lin CS
    Arch Virol; 2008; 153(9):1633-42. PubMed ID: 18626568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy.
    Pease LF; Lipin DI; Tsai DH; Zachariah MR; Lua LH; Tarlov MJ; Middelberg AP
    Biotechnol Bioeng; 2009 Feb; 102(3):845-55. PubMed ID: 18958863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular uptake of virus-like particles through immobilization on a sialic acid-displaying solid surface.
    Ohtake N; Niikura K; Suzuki T; Nagakawa K; Sawa H; Ijiro K
    Bioconjug Chem; 2008 Feb; 19(2):507-15. PubMed ID: 18179162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular construction of bionanoparticles: chimaeric SIV p17-HIV I p6 nanoparticles with minimal viral protein content.
    Costa MJ; Pedro L; de Matos AP; Aires-Barros MR; Belo JA; Goncalves J; Ferreira GN
    Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):35-43. PubMed ID: 17391101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
    Pan Y; Zhang Y; Jia T; Zhang K; Li J; Wang L
    FEBS J; 2012 Apr; 279(7):1198-208. PubMed ID: 22309233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.